BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21641019)

  • 1. Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies.
    Pai M; Evans NS; Shah SJ; Green D; Cook D; Crowther MA
    Thromb Res; 2011 Nov; 128(5):422-30. PubMed ID: 21641019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin use and the prevention of venous thromboembolism: a meta-analysis.
    Agarwal V; Phung OJ; Tongbram V; Bhardwaj A; Coleman CI
    Int J Clin Pract; 2010 Sep; 64(10):1375-83. PubMed ID: 20716146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Statins can maybe reduce the risk of venous thromboembolism].
    Toft-Petersen AP; Thomsen RW; Schmidt EB; Larsen TB
    Ugeskr Laeger; 2011 May; 173(22):1558-63. PubMed ID: 21627898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis.
    Kunutsor SK; Seidu S; Khunti K
    Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia, statins, and venous thromboembolism.
    Poredos P; Jezovnik MK
    Semin Thromb Hemost; 2011 Nov; 37(8):897-902. PubMed ID: 22198854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting the JUPITER trial: statins can prevent VTE, but more study is needed.
    Perez A; Bartholomew JR
    Cleve Clin J Med; 2010 Mar; 77(3):191-4. PubMed ID: 20200169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use in patients with nephrotic syndrome is associated with a lower risk of venous thromboembolism.
    Resh M; Mahmoodi BK; Navis GJ; Veeger NJ; Lijfering WM
    Thromb Res; 2011 May; 127(5):395-9. PubMed ID: 21277007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins are associated with low risk of venous thromboembolism in patients with cancer: a prospective and observational cohort study.
    Lötsch F; Königsbrügge O; Posch F; Zielinski C; Pabinger I; Ay C
    Thromb Res; 2014 Nov; 134(5):1008-13. PubMed ID: 25234407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effect of statins in venous thrombosis risk reduction.
    Khemasuwan D; Chae YK; Gupta S; Carpio A; Yun JH; Neagu S; Lucca AB; Valsecchi ME; Mora JI
    Am J Med; 2011 Sep; 124(9):852-9. PubMed ID: 21783169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins decrease the occurrence of venous thromboembolism in patients with cancer.
    Khemasuwan D; Divietro ML; Tangdhanakanond K; Pomerantz SC; Eiger G
    Am J Med; 2010 Jan; 123(1):60-5. PubMed ID: 20102993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for primary prevention of venous thromboembolism.
    Li L; Sun T; Zhang P; Tian J; Yang K
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008203. PubMed ID: 22161421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies.
    Kunutsor SK; Seidu S; Khunti K
    Eur Heart J; 2017 May; 38(20):1608-1612. PubMed ID: 28369602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and venous thromboembolism: do they represent a viable therapeutic agent?
    Kunutsor SK; Whitehouse MR; Blom AW; Laukkanen JA
    Expert Rev Cardiovasc Ther; 2017 Aug; 15(8):629-637. PubMed ID: 28724320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for the prevention of venous thromboembolism? a narrative review.
    Sehdev A; Wanner N; Pendleton RC
    Hosp Pract (1995); 2012 Aug; 40(3):13-8. PubMed ID: 23086090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of Statins for Prevention of Venous Thromboembolism.
    Chaffey P; Thompson M; Pai AD; Tafreshi AR; Tafreshi J; Pai RG
    Am J Cardiol; 2018 Jun; 121(11):1436-1440. PubMed ID: 29576234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
    Ageno W; Becattini C; Brighton T; Selby R; Kamphuisen PW
    Circulation; 2008 Jan; 117(1):93-102. PubMed ID: 18086925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P
    J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.